These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6380974

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The significance of wheezing in chronic airflow obstruction.
    Marini JJ, Pierson DJ, Hudson LD, Lakshminarayan S.
    Am Rev Respir Dis; 1979 Nov; 120(5):1069-72. PubMed ID: 507523
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
    Minatoya H.
    J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Cardiopulmonary effects of terbutaline and a bronchodilator combination in chronic obstructive pulmonary disease.
    Pierson DJ, Hudson LD, Stark K, Hedgecock M.
    Chest; 1980 Feb; 77(2):176-82. PubMed ID: 6986238
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Volumetric correction of the maximal expiratory flow 25-75% in chronic obstructive bronchopneumopathies].
    Dull WL, Alexander MR, Kasik JE.
    Rev Fr Mal Respir; 1982 Feb; 10(5):337-44. PubMed ID: 7178638
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cardiac and pulmonary effects of therapy with albuterol and isoproterenol.
    Whitsett TL, Manion CV.
    Chest; 1978 Sep; 74(3):251-5. PubMed ID: 357097
    [Abstract] [Full Text] [Related]

  • 33. Pulmonary resistance and maximal expiratory flowrate following isoprenaline in patients with chronic obstructive lung disease.
    Stănescu DC, Clément J, Van de Woestijne KP.
    Thorax; 1973 Nov; 28(6):716-20. PubMed ID: 4787983
    [Abstract] [Full Text] [Related]

  • 34. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS.
    Adv Ther; 1995 Nov; 12(3):157-63. PubMed ID: 10155050
    [Abstract] [Full Text] [Related]

  • 35. The use of expiratory forced flows for determining response to bronchodilator therapy.
    Boushy SF.
    Chest; 1972 Nov; 62(5):534-41. PubMed ID: 4563061
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Sch 1000: a new anticholinergic bronchodilator.
    Gross MJ.
    Am Rev Respir Dis; 1975 Dec; 112(6):823-8. PubMed ID: 128306
    [Abstract] [Full Text] [Related]

  • 38. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A, Nishimura K, Koyama H, Izumi T.
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.